Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nantkwest Inc CS (NK)

Nantkwest Inc CS (NK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nantkwest Inc CS 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 USA

www.nantkwest.com P: 858-633-0300

Description:

NantKwest, Inc. is a clinical-stage immunotherapy company. The Company's product candidates include aNK, haNK and taNK for the treatment of cancers, infectious and inflammatory diseases. It is focused on harnessing the power of the innate immune system by using the natural killer cell. NantKwest, Inc. is headquartered in Cardiff-by-the-Sea, California.

Key Statistics

Overview:

Market Capitalization, $K 3,552,620
Shares Outstanding, K 109,345
Annual Sales, $ 110 K
Annual Net Income, $ -92,380 K
Last Quarter Sales, $ 20 K
Last Quarter Net Income, $ -32,140 K
60-Month Beta 2.38
% of Insider Shareholders 71.73%
% of Institutional Shareholders 10.62%
Float, K 30,912
% Float 28.27%

Growth:

1-Year Return 638.41%
3-Year Return 690.51%
5-Year Return 346.91%
5-Year Revenue Growth -54.17%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 03/24/21
Earnings Per Share ttm -0.39
EPS Growth vs. Prev Qtr -5.26%
EPS Growth vs. Prev Year -17.65%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

NK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -68.66%
Return-on-Assets % -56.37%
Profit Margin % -83,981.82%
Debt/Equity 0.00
Price/Sales 27,858.35
Price/Cash Flow N/A
Price/Book 30.17
Book Value/Share 1.08
Interest Coverage -2,308.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar